Cipla Seeks Growth For Biosimilar Arm Via Tie-Ups

Cipla Ltd. plans to launch multiple biosimilars in the next one year, aided by its tie-ups with other firms."We’ll target South Africa, Australia, India and emerging markets," Kedar Upadhye, the company’s joint president and global chief finance officer, told BloombergQuint in an interview. He expects revenue share from the partnerships in these regions to grow.A few products, he said, are already on the shelves in India.The partners...